Emergence of Letermovir-resistant HCMV UL56 mutant during rescue treatment in a liver transplant recipient with ganciclovir-resistant infection HCMV: a case report

Abstract Background Human Cytomegalovirus (HCMV) still represents a crucial concern in solid organ transplant recipients (SOTRs) and the use of antiviral therapy are limited by side effects and the selection of viral mutations conferring antiviral drug resistance. Case presentation Here we reported...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Stefania Paolucci, Giulia Campanini, Irene Cassaniti, Alessandra Tebaldi, Federica Novazzi, Alice Fratini, Antonella Meini, Federica Girelli, Laura Palumbo, Alessandro Plebani, Fausto Baldanti
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2021-09-01
Ráidu:	BMC Infectious Diseases
Fáttát:	Case report HCMV Letermovir
Liŋkkat:	https://doi.org/10.1186/s12879-021-06694-4
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!